> "Sometimes I wonder if we wouldn't be better with real centrally planned drug production" Or we could simply subsidize the modest overproduction of such crit

> "Sometimes I wonder if we wouldn't be better with real centrally planned drug production" Or we could simply subsidize the modest overproduction of such critical, low-profit generics, selling or donating any surplus [1] not unlike what we do with food staples. This would encourage additional production, making any drops, for whatever reasons (regulatory, accidental, business-related) less of a systemic threat. In a world of imperfect solutions, I'll take that over additional regulatory bureaucracy or central planning. [1] I realize this isn't ideal and 'dumping' the surplus may well do more long-term harm in any communities we might help, short term, via donation. But that can be studied and determined. And, frankly, a robust public health system is important enough that even if we have to incinerate the surplus, subsidized overproduction may well be worth doing.